SL Science Holding Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SLBT research report →
Price Chart
About the company
Horizon Space Acquisition II Corp. aims to achieve strategic business combinations with other companies. This objective can be fulfilled through various transactional structures, including mergers, exchanges of shares, acquisitions of assets, direct purchases of stock, recapitalizations, or other forms of corporate reorganization.
- CEO
- Mingyu Li
- IPO
- 2025
- Employees
- 2
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on SLBT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $24.70M
- P/E
- 0.00
- PEG
- 0.00
- P/S
- 11.24
- P/B
- 0.00
- EV/EBITDA
- -6.32
- Div Yield
- 0.00%
- Gross Margin
- 35.27%
- Op Margin
- -174.65%
- Net Margin
- -173.85%
- ROE
- -95.36%
- ROIC
- -153.66%
Latest fiscal year · YoY change
- Revenue
- $2.20M-34.7%
- Gross Profit
- $775.06K-59.9%
- Op Income
- $-3,837,488
- Net Income
- $-3,819,818-220.6%
- EPS
- $0.00+0.0%
- OCF Growth
- -781.7%
- FCF Growth
- -919.1%
- 52W High
- $14.50
- 52W Low
- $2.80
- 50D MA
- $6.56
- 200D MA
- $8.96
- Beta
- 0.09
- RSI (14)
- 38
- Avg Volume
- 741.37K
No earnings-call transcripts are available for SLBT yet.
- Free Float
- 81.0%
- Shares Outstanding
- 7.92M
- Float Shares
- 6.41M
Our SLBT coverage
Recent articles, reports, and earnings notes.
Want a deeper read on SLBT?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology
globenewswire.com · Jul 17
SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma
globenewswire.com · Jul 10
SL Science Holding, Alamos Gold And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com · Jun 22
SL Science Holding Limited Reports Full Year 2025 Financial Results
globenewswire.com · Jun 18
SL BIO Ltd. and Horizon Space Acquisition II Announce Closing of Business Combination and Listing on the Nasdaq Global Market
globenewswire.com · Jun 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
Bullish or bearish?
Where do you stand on SLBT?